{"id":"https://genegraph.clinicalgenome.org/r/5c0758cf-a5b6-4365-a272-00537f383e81v1.0","type":"EvidenceStrengthAssertion","dc:description":"HOGA1 was first reported in relation to autosomal recessive Primary Hyperoxaluria III (HP3) in 2010 (Belostotsky et al., PMID: 20797690). 17 variants (missense, in-frame indel, splicing, frameshift, nonsense) that have been reported in 16 probands in 5 publications (PMIDs: 20797690, 21896830, 22391140, 28711958, 31123811) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached, The mechanism of disease appears to be loss-of-function. This gene-disease relationship is also supported by experimental evidence (expression-level evidence; GTEx and Humphreyâ€™s Lab expression data). A mouse model was evaluated, but was not scored as the mice lacked urinary oxalate excretion, a key part of the human phenotype. In summary, there is definitive evidence supporting the relationship between HOGA1 and autosomal recessive HP3. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Tubulopathy GCEP on the meeting date 5/30/2024 (SOP Version 10). ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/5c0758cf-a5b6-4365-a272-00537f383e81","GCISnapshot":"https://genegraph.clinicalgenome.org/r/0c6ee29c-08c1-4cdd-b78d-9a5bda8ace20","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/0c6ee29c-08c1-4cdd-b78d-9a5bda8ace20_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10067","date":"2024-10-07T16:13:47.829Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/0c6ee29c-08c1-4cdd-b78d-9a5bda8ace20_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10067","date":"2024-05-16T16:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0c6ee29c-08c1-4cdd-b78d-9a5bda8ace20_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/04acabdf-2d2b-418e-bdd1-9056fd4a178e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4bfb85fc-0b04-4f6d-a535-bc33f012167e","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4bfb85fc-0b04-4f6d-a535-bc33f012167e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"This variant is p.Tyr39Ter (c.117C>A). It is not an in-frame deletion of residue 39.","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/4bfb85fc-0b04-4f6d-a535-bc33f012167e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22391140","allele":{"id":"https://genegraph.clinicalgenome.org/r/3e2ab071-25dd-4a3a-b090-3d906ac2503a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138413.4(HOGA1):c.117C>A (p.Tyr39del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA203942"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/04acabdf-2d2b-418e-bdd1-9056fd4a178e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22391140","rdfs:label":"p.Tyr39Ter & p.Arg70Ter ","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":9,"allele":{"id":"https://genegraph.clinicalgenome.org/r/3e2ab071-25dd-4a3a-b090-3d906ac2503a"},"firstTestingMethod":"Whole genome shotgun sequencing","phenotypeFreeText":"left renal stone (93 % calcium oxalate)","phenotypes":["obo:HP_0000790","obo:HP_0003159","obo:HP_0000787"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/4bfb85fc-0b04-4f6d-a535-bc33f012167e_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/a423853c-2193-4898-b1e2-8f46ecf15bdd_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dcf4570c-7c62-46f1-beff-e85fc04c7ac9","type":"EvidenceLine","dc:description":"Downgrading for homozygosity/potential consanguinity. ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dcf4570c-7c62-46f1-beff-e85fc04c7ac9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28711958","allele":{"id":"https://genegraph.clinicalgenome.org/r/7db8c08b-4dfd-445d-9cc2-acee207f8516","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138413.4(HOGA1):c.346C>T (p.Gln116del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA203950"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/a423853c-2193-4898-b1e2-8f46ecf15bdd","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28711958","rdfs:label":"p.Gln116Ter (homozygous)","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":1,"allele":{"id":"https://genegraph.clinicalgenome.org/r/7db8c08b-4dfd-445d-9cc2-acee207f8516"},"detectionMethod":"AGXT, GRHPR, and HOGA1 sequenced.","firstTestingMethod":"Genotyping","phenotypeFreeText":"chronic urolithiasis, no stones at follow up at 8.4 yrs. old","phenotypes":["obo:HP_0034368","obo:HP_0003159"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/dcf4570c-7c62-46f1-beff-e85fc04c7ac9_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/37de2d27-5c3c-4e62-b02d-7f642db20203_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c3ce025f-b503-4fcd-b5d5-d940d48bcfbe","type":"EvidenceLine","dc:description":"This variant is p.Arg70Ter (c.208C>T). It is not an in-frame deletion of residue 70. ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c3ce025f-b503-4fcd-b5d5-d940d48bcfbe_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22391140","allele":{"id":"https://genegraph.clinicalgenome.org/r/37f108bb-5418-4fcb-a45e-811f39e6d66e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138413.4(HOGA1):c.208C>T (p.Arg70del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA203945"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/37de2d27-5c3c-4e62-b02d-7f642db20203","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22391140","rdfs:label":"c.700+5G>T & p.Arg70Ter in trans","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/37f108bb-5418-4fcb-a45e-811f39e6d66e"},"firstTestingMethod":"Whole genome shotgun sequencing","phenotypeFreeText":" bilateral kidney stones (94 % calcium oxalate)","phenotypes":["obo:HP_0003159","obo:HP_0000787","obo:HP_0000010"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/c3ce025f-b503-4fcd-b5d5-d940d48bcfbe_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/a35f435b-3e4e-4314-b1f7-9f9e9ec28434_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/65da3eb5-9332-4463-8e20-bc89fccb3848","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/65da3eb5-9332-4463-8e20-bc89fccb3848_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis showed harmful impact of mutations in that they dramatically reduce stability, impact localization, and trigger aggregation (PMID: 22771891).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/65da3eb5-9332-4463-8e20-bc89fccb3848_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21896830","allele":{"id":"https://genegraph.clinicalgenome.org/r/f76e888d-f7b0-4fd6-b996-504e172bc4f0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138413.4(HOGA1):c.839C>T (p.Thr280Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA203964"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a35f435b-3e4e-4314-b1f7-9f9e9ec28434","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21896830","rdfs:label":"p.Thr280Ile & c.700+5G>T in trans ","allele":{"id":"https://genegraph.clinicalgenome.org/r/f76e888d-f7b0-4fd6-b996-504e172bc4f0"},"detectionMethod":"All exons and flanking introns of HOGA1 from blood leukocytes sequenced, patient did not have HPI or HPII (caused by AGXT and GRHPR respectively). ","firstTestingMethod":"Genotyping","phenotypes":"obo:HP_0003159","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/65da3eb5-9332-4463-8e20-bc89fccb3848_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/155801bf-b9b8-47b6-850c-72190edf9bf5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/454497b6-67a0-477e-b78a-743dde050518","type":"EvidenceLine","dc:description":"Scoring this case at 0.5 for the high recurrence of this mutation. ","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/454497b6-67a0-477e-b78a-743dde050518_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"RT-PCR analysis showed that the variant leads to a 51 bp longer product (412 bp) vs. the wild type (361 bp) (mutant extends protein by 17 amino acids) (PMID: 21896830). ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/454497b6-67a0-477e-b78a-743dde050518_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22391140","allele":{"id":"https://genegraph.clinicalgenome.org/r/0456bf44-06af-4ad0-8796-a180f90a313c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138413.4(HOGA1):c.700+5G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA346911"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/155801bf-b9b8-47b6-850c-72190edf9bf5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22391140","rdfs:label":"c.700+5G>T (homozyg.)","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/0456bf44-06af-4ad0-8796-a180f90a313c"},"firstTestingMethod":"Whole genome shotgun sequencing","phenotypeFreeText":"Bilateral calcium oxalate kidney stones","phenotypes":["obo:HP_0003159","obo:HP_0000787"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/454497b6-67a0-477e-b78a-743dde050518_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/aeed80d6-e294-4b1a-a64f-dd1cf4433c1a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aeb659ee-0ffe-49e5-a2ac-6631c5de3a39","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aeb659ee-0ffe-49e5-a2ac-6631c5de3a39_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"This is p.Arg255Ter. It is not an in-frame deletion at residue 255. Functional analysis (RT-PCR) showed that mutated nucleotide had equal expression as wild-type nucleotide suggesting that mutation does not lead to NMD. However, functional analysis showed harmful impact of the mutation in that it dramatically reduced stability, impacted localization, and triggered aggregation (PMID: 22771891).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/aeb659ee-0ffe-49e5-a2ac-6631c5de3a39_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21896830","allele":{"id":"https://genegraph.clinicalgenome.org/r/9d7a41ab-ae7a-4804-9896-324871952c5f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138413.4(HOGA1):c.763C>T (p.Arg255del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA203961"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/aeed80d6-e294-4b1a-a64f-dd1cf4433c1a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21896830","rdfs:label":"p.Arg255Ter & c.700+5G>T in trans","ageType":"AgeAtReport","ageUnit":"Months","ageValue":9,"allele":{"id":"https://genegraph.clinicalgenome.org/r/9d7a41ab-ae7a-4804-9896-324871952c5f"},"detectionMethod":"All exons and flanking introns of HOGA1 from blood leukocytes sequenced, patient did not have HPI or HPII (caused by AGXT and GRHPR respectively)","firstTestingMethod":"Genotyping","phenotypeFreeText":" 100 % monohydrate form kidney stones; urolithiasis on left side","phenotypes":["obo:HP_0000787","obo:HP_0003159","obo:HP_0034368"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/aeb659ee-0ffe-49e5-a2ac-6631c5de3a39_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a93d9a9c-bafa-4403-acbf-5957d56a0c7b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/43cde334-fc09-45b7-9e0c-75304d2e0497","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/43cde334-fc09-45b7-9e0c-75304d2e0497_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31123811","allele":{"id":"https://genegraph.clinicalgenome.org/r/395c7d79-f389-402f-8490-fbf4c1a9599b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138413.4(HOGA1):c.70del (p.Val24SerfsTer19)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2499220516"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/a93d9a9c-bafa-4403-acbf-5957d56a0c7b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31123811","rdfs:label":"p.Val24Serfs*19 & c.834_835+1delinsTT","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":20,"allele":{"id":"https://genegraph.clinicalgenome.org/r/395c7d79-f389-402f-8490-fbf4c1a9599b"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"bilateral calcium oxalate stones; stone residues","phenotypes":["obo:HP_0000790","obo:HP_0000787","obo:HP_0003159"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/43cde334-fc09-45b7-9e0c-75304d2e0497_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/9e11f111-2147-4bc2-b3c9-22d37533704e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2af202e1-be8f-453f-b563-595794ddc9b1","type":"EvidenceLine","dc:description":"The splicing variant is not scored for this proband as it was already scored in another case. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2af202e1-be8f-453f-b563-595794ddc9b1_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis showed harmful impact of mutations in that they dramatically reduce stability, impact localization, and trigger aggregation (PMID: 22771891).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/2af202e1-be8f-453f-b563-595794ddc9b1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22391140","allele":{"id":"https://genegraph.clinicalgenome.org/r/a8b726d0-1de8-41df-96d9-413861761f33","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138413.4(HOGA1):c.907C>T (p.Arg303Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA203968"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9e11f111-2147-4bc2-b3c9-22d37533704e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22391140","rdfs:label":"c.700+5G>T & p.Arg303Cys in trans ","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/a8b726d0-1de8-41df-96d9-413861761f33"},"firstTestingMethod":"Whole genome shotgun sequencing","phenotypeFreeText":"left renal and bladder stones (100 % calcium oxalate, 68 % monohydrate form) ","phenotypes":["obo:HP_0000787","obo:HP_0000790","obo:HP_0010474","obo:HP_0003159"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/2af202e1-be8f-453f-b563-595794ddc9b1_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/24317861-0c23-4d5b-9479-3e7ca6698116_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9e0d215-9e51-4db1-b1ac-56111759acec","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9e0d215-9e51-4db1-b1ac-56111759acec_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"RNA analysis confirmed out-of-frame skipping of exon 6, but product did not undergo nonsense-mediated decay (PMID: 26340091).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/e9e0d215-9e51-4db1-b1ac-56111759acec_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31123811","allele":{"id":"https://genegraph.clinicalgenome.org/r/4beba9f2-380d-46f3-b545-ed866055f9e8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000010.11:g.97601990_97601991delinsTT","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA913190080"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2878b431-e2f2-45d6-980c-e4a891f8af38","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2878b431-e2f2-45d6-980c-e4a891f8af38_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"RNA analysis confirmed out-of-frame skipping of exon 6; truncated product and wild type in 2:1 ratio.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/2878b431-e2f2-45d6-980c-e4a891f8af38_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31123811","allele":{"id":"https://genegraph.clinicalgenome.org/r/478601f5-c61b-432a-bfa0-e1d8b9adee8d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138413.4(HOGA1):c.834G>A (p.Ala278=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA203981"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/24317861-0c23-4d5b-9479-3e7ca6698116","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31123811","rdfs:label":"c.834_835+1delinsTT & p.Ala278Ala ","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":24,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/478601f5-c61b-432a-bfa0-e1d8b9adee8d"},{"id":"https://genegraph.clinicalgenome.org/r/4beba9f2-380d-46f3-b545-ed866055f9e8"}],"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"bilateral stones, stone residue","phenotypes":["obo:HP_0003159","obo:HP_0034368","obo:HP_0000787"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/2878b431-e2f2-45d6-980c-e4a891f8af38_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/e9e0d215-9e51-4db1-b1ac-56111759acec_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/85938295-cd12-47ab-abd6-4d019503729b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/85ab2eb8-5133-4746-a6f5-b35f20a31095","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/85ab2eb8-5133-4746-a6f5-b35f20a31095_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis showed harmful impact of mutations in that they dramatically reduce stability, impact localization, and trigger aggregation (PMID: 22771891).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/85ab2eb8-5133-4746-a6f5-b35f20a31095_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21896830","allele":{"id":"https://genegraph.clinicalgenome.org/r/8d243ee3-2f34-417f-be91-e92fe8e1b51b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138413.4(HOGA1):c.569C>T (p.Pro190Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA203955"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/85938295-cd12-47ab-abd6-4d019503729b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21896830","rdfs:label":"c.700+5G>T & p.Pro190Leu in trans ","ageType":"AgeAtReport","ageUnit":"Years","ageValue":19,"allele":{"id":"https://genegraph.clinicalgenome.org/r/8d243ee3-2f34-417f-be91-e92fe8e1b51b"},"detectionMethod":"All exons and flanking introns of HOGA1 from blood leukocytes sequenced, patient did not have HPI or HPII (caused by AGXT and GRHPR respectively)\n","firstTestingMethod":"Genotyping","phenotypeFreeText":"urolithiasis (numerous); gross hematuria","phenotypes":["obo:HP_0000790","obo:HP_0003159","obo:HP_0034368","obo:HP_0000787"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/85ab2eb8-5133-4746-a6f5-b35f20a31095_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8d4dc74e-1e05-4062-b48f-e3fa1b414663_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6ccafbfe-7c59-4e75-95d8-847fc80d1343","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6ccafbfe-7c59-4e75-95d8-847fc80d1343_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28711958","allele":{"id":"https://genegraph.clinicalgenome.org/r/ab7f6376-af10-4ab1-bad4-8449ecd94de1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138413.4(HOGA1):c.158del (p.Asp53AlafsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA203983"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/8d4dc74e-1e05-4062-b48f-e3fa1b414663","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28711958","rdfs:label":"p.Asp53Alafs*32 & c.700+5G>T in trans ","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":10,"allele":{"id":"https://genegraph.clinicalgenome.org/r/ab7f6376-af10-4ab1-bad4-8449ecd94de1"},"detectionMethod":"AGXT, GRHPR, and HOGA1 sequenced ","firstTestingMethod":"Genotyping","phenotypeFreeText":"two stones in each kidney at follow up at 17 yrs.\n","phenotypes":["obo:HP_0003159","obo:HP_0000787","obo:HP_0000010","obo:HP_0034368"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/6ccafbfe-7c59-4e75-95d8-847fc80d1343_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/f2827c1f-962c-4890-adc7-92a66049e5ab_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/96f877ea-9da8-47bd-aa06-e7e12cb4ae7d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/96f877ea-9da8-47bd-aa06-e7e12cb4ae7d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis showed harmful impact of mutations in that they dramatically reduce stability, impact localization, and trigger aggregation (PMID: 22771891).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/96f877ea-9da8-47bd-aa06-e7e12cb4ae7d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22391140","allele":{"id":"https://genegraph.clinicalgenome.org/r/ab50c2d2-32e2-4948-8b10-6343648f06a6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138413.4(HOGA1):c.860G>T (p.Gly287Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA113813"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/94d2c1de-50f6-447e-8f9e-c65e4f4d403f","type":"EvidenceLine","dc:description":"This variant is scored a second time as it is highly recurrent. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/94d2c1de-50f6-447e-8f9e-c65e4f4d403f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis showed harmful impact of mutations in that they dramatically reduce stability, impact localization, and trigger aggregation (PMID: 22771891).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/94d2c1de-50f6-447e-8f9e-c65e4f4d403f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22391140","allele":{"id":"https://genegraph.clinicalgenome.org/r/bdf0312c-6624-4274-9a2b-0a217d91a90b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138413.4(HOGA1):c.944_946del (p.Glu315del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA339783"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f2827c1f-962c-4890-adc7-92a66049e5ab","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22391140","rdfs:label":"p.Glu315del & p.Gly287Val in trans","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":19,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/bdf0312c-6624-4274-9a2b-0a217d91a90b"},{"id":"https://genegraph.clinicalgenome.org/r/ab50c2d2-32e2-4948-8b10-6343648f06a6"}],"firstTestingMethod":"Whole genome shotgun sequencing","phenotypeFreeText":"renal stones (100 % calcium oxalate, 88 % monohydrate form)","phenotypes":["obo:HP_0000790","obo:HP_0003159","obo:HP_0000787"],"sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/94d2c1de-50f6-447e-8f9e-c65e4f4d403f_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/96f877ea-9da8-47bd-aa06-e7e12cb4ae7d_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/432928b4-8f9f-416e-9a2a-c6e9c89d2875_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9bdec92-05cd-411d-9b5c-7ff30772fbff","type":"EvidenceLine","dc:description":"Total score for proband should technically by 0.6 (0.1 * 2 + 0.4), since the functional evidence is only counted once to upgrade 0.4 pts. ","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9bdec92-05cd-411d-9b5c-7ff30772fbff_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis showed harmful impact of mutations in that they dramatically reduce stability, impact localization, and trigger aggregation (PMID: 22771891).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/e9bdec92-05cd-411d-9b5c-7ff30772fbff_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20797690","allele":{"id":"https://genegraph.clinicalgenome.org/r/88311e41-b83b-431e-bc2e-0e66ecee8adb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138413.4(HOGA1):c.769T>G (p.Cys257Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA113818"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/432928b4-8f9f-416e-9a2a-c6e9c89d2875","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20797690","rdfs:label":"p.Cys257Gly (homozygous)","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":4,"allele":{"id":"https://genegraph.clinicalgenome.org/r/88311e41-b83b-431e-bc2e-0e66ecee8adb"},"detectionMethod":"High density SNP microarray analysis and linkage analysis were done; the patient did not have primary hyperoxaluria type 1 or 2 (caused by AGT and GRHPR, respectively). ","firstTestingMethod":"Linkage analysis","phenotypeFreeText":"first kidney stone at age 4, last at age 12 (last evaluated at age 12)","phenotypes":["obo:HP_0003159","obo:HP_0000787"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e9bdec92-05cd-411d-9b5c-7ff30772fbff_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/289bf5c7-a1b2-47e8-80b1-b3ce834f7002_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9794610-0ed3-4bac-85ef-0e4498133a0b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9794610-0ed3-4bac-85ef-0e4498133a0b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis showed harmful impact of mutations in that they dramatically reduce stability, impact localization, and trigger aggregation (PMID: 22771891).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/e9794610-0ed3-4bac-85ef-0e4498133a0b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20797690","allele":{"id":"https://genegraph.clinicalgenome.org/r/bdf0312c-6624-4274-9a2b-0a217d91a90b"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2c7cb259-8e80-4e77-98d4-eb76335c559d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2c7cb259-8e80-4e77-98d4-eb76335c559d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis showed harmful impact of mutations in that they dramatically reduce stability, impact localization, and trigger aggregation (PMID: 22771891).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/2c7cb259-8e80-4e77-98d4-eb76335c559d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20797690","allele":{"id":"https://genegraph.clinicalgenome.org/r/4e9717fd-3430-4750-bcb3-807b23852ab3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138413.4(HOGA1):c.289C>T (p.Arg97Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA113814"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/289bf5c7-a1b2-47e8-80b1-b3ce834f7002","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20797690","rdfs:label":"p.Arg97Cys & p.Glu315del in trans","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":9,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/bdf0312c-6624-4274-9a2b-0a217d91a90b"},{"id":"https://genegraph.clinicalgenome.org/r/4e9717fd-3430-4750-bcb3-807b23852ab3"}],"detectionMethod":"High density SNP microarray analysis and linkage analysis were done; the patient did not have primary hyperoxaluria type 1 or 2 (caused by AGT and GRHPR, respectively) ","firstTestingMethod":"Linkage analysis","phenotypeFreeText":"the proband had his first kidney stone at 0.75 yrs., last stone at 23 yrs. (when last evaluated); his affected family member (a male) had kidney stones observed at age 2 ","phenotypes":["obo:HP_0003159","obo:HP_0000787"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/e9794610-0ed3-4bac-85ef-0e4498133a0b_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/2c7cb259-8e80-4e77-98d4-eb76335c559d_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/105520af-db91-495d-b6c3-ebd88f258e35_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a576c5fa-6ae9-4298-b6cc-a5295804ef9a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a576c5fa-6ae9-4298-b6cc-a5295804ef9a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"RT-PCR analysis showed that the variant leads to a 51 bp longer product (412 bp) vs. the wild type (361 bp) (mutant extends protein by 17 amino acids) (PMID: 21896830). ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/a576c5fa-6ae9-4298-b6cc-a5295804ef9a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20797690","allele":{"id":"https://genegraph.clinicalgenome.org/r/0456bf44-06af-4ad0-8796-a180f90a313c"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/90f3f61f-86ea-4374-893f-43be320c8ceb","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/90f3f61f-86ea-4374-893f-43be320c8ceb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis showed harmful impact of mutations in that they dramatically reduce stability, impact localization, and trigger aggregation (PMID: 22771891).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/90f3f61f-86ea-4374-893f-43be320c8ceb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20797690","allele":{"id":"https://genegraph.clinicalgenome.org/r/70d3ff21-f983-4965-9b24-3fb97821697e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_138413.4(HOGA1):c.209G>C (p.Arg70Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA113816"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/105520af-db91-495d-b6c3-ebd88f258e35","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20797690","rdfs:label":"p.Arg70Pro & c.700+5G>T in trans ","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":4,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/70d3ff21-f983-4965-9b24-3fb97821697e"},{"id":"https://genegraph.clinicalgenome.org/r/0456bf44-06af-4ad0-8796-a180f90a313c"}],"detectionMethod":"High density SNP microarray analysis and linkage analysis were done; the patient did not have primary hyperoxaluria type 1 or 2 (caused by AGT and GRHPR, respectively).","firstTestingMethod":"Linkage analysis","phenotypeFreeText":"first kidney stone at age 4.3, last at age 13 (last evaluated at age 15)","phenotypes":["obo:HP_0003159","obo:HP_0000787"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/a576c5fa-6ae9-4298-b6cc-a5295804ef9a_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/90f3f61f-86ea-4374-893f-43be320c8ceb_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/0c6ee29c-08c1-4cdd-b78d-9a5bda8ace20_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0c6ee29c-08c1-4cdd-b78d-9a5bda8ace20_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/839ad077-3bb5-48d2-9809-38b1da5d1117","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/37175c55-ff9a-4a6e-abf8-bdbcceabdd88","type":"Finding","dc:description":"There is high expression in the cortex and medulla of kidney, particularly in the cortex. High kidney expression seen in Humphrey's Lab data as well. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20797690","rdfs:label":"GTEx & Humphrey's Lab expression (NOT from this PMID)","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0.5}],"evidenceStrength":"Definitive","sequence":9121,"specifiedBy":"GeneValidityCriteria10","strengthScore":12.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/FLthvgV93uo","type":"GeneValidityProposition","disease":"obo:MONDO_0013327","gene":"hgnc:25155","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_0c6ee29c-08c1-4cdd-b78d-9a5bda8ace20-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}